Option Care (OPCH) CEO buys 12,500 shares in open market

Filing Impact

(High)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Option Care Health, Inc. Chief Executive Officer John Charles Rademacher reported an open-market purchase of 12,500 shares of common stock on May 4, 2026 at a weighted average price of $21.1765 per share. Following this transaction, he directly owns 695,152 common shares.

The shares were bought in multiple trades that day at prices ranging from $21.14 to $21.18 per share, indicating a modest incremental increase to his existing equity stake in the company.

Insider Trade Summary

Net Buyer: 12,500 shares ($264,706)

Net Buy 1 txn

Insider RADEMACHER JOHN CHARLES

Role Chief Executive Officer

Bought 12,500 shs ($265K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	12,500	$21.1765	$265K

Holdings After Transaction: Common Stock — 695,152 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares purchased: 12,500 shares Weighted average purchase price: $21.1765 per share Post-transaction holdings: 695,152 shares +2 more

5 metrics

Shares purchased 12,500 shares Open-market purchase of common stock on May 4, 2026

Weighted average purchase price $21.1765 per share Price paid for 12,500 shares on May 4, 2026

Post-transaction holdings 695,152 shares CEO’s direct ownership after May 4, 2026 trade

Trade price range low $21.14 per share Lowest price among multiple trades on May 4, 2026

Trade price range high $21.18 per share Highest price among multiple trades on May 4, 2026

Key Terms

open-market purchase, weighted average price, Form 4, transaction code "P"

4 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"Reflects the weighted average price of 12,500 shares of common stock"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code "P" regulatory

"transaction_code_description: "Purchase in open market or private transaction""

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 05:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RADEMACHER JOHN CHARLES

(Last)

(First)

(Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN

ILLINOIS

60015

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/04/2026		P		12,500	A	$21.1765⁽¹⁾	695,152	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects the weighted average price of 12,500 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on May 4, 2026 with purchase prices ranging from $21.14 to $21.18 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Rademacher	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Option Care Health (OPCH) report?

Option Care Health reported that its CEO, John Charles Rademacher, bought 12,500 shares of common stock. The open-market purchase occurred on May 4, 2026, and modestly increased his direct ownership stake in the company.

How many Option Care Health (OPCH) shares does the CEO hold after this trade?

After the May 4, 2026 open-market purchase, CEO John Charles Rademacher directly owns 695,152 shares of Option Care Health common stock. This figure reflects his position immediately following the acquisition of 12,500 additional shares.

At what price did the Option Care Health (OPCH) CEO buy shares?

The CEO bought 12,500 Option Care Health shares at a weighted average price of $21.1765. According to the footnote, individual trade prices on May 4, 2026 ranged from $21.14 to $21.18 per share.

Was the Option Care Health (OPCH) CEO trade an open-market purchase?

Yes. The Form 4 classifies the transaction as an open-market purchase of common stock. It uses transaction code “P,” indicating shares were bought in market or private transactions rather than being granted as compensation or resulting from option exercises.

Does the Option Care Health (OPCH) Form 4 mention multiple trade prices?

Yes. The filing notes that 12,500 shares were purchased in multiple trades on May 4, 2026. Purchase prices ranged between $21.14 and $21.18 per share, with the reported $21.1765 figure reflecting the weighted average price.